Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease

Table 3

Univariate and multiple regression analysis of NGAL in CKD patients.

(a) In vivo

Variable	Partial	β	value
ESR	0.35 (p  )	0.32	0.001
hs-CRP	0.81 (p  )	0.81	<0.0001
IL-17	0.64 (p  )	0.32	0.006
IL-6	0.90 (p  )	0.78	<0.0001
IFN-γ	0.90 (p  )	0.75	<0.0001
TNF-α	0.59 (p  )	0.76	<0.0001
IL-1β	0.51 (p  )	0.23	0.13

(b) In vitro

Variable	Partial	β	value
ESR	0.35 (p  )	0.75	0.4
hs-CRP	0.36 (p  )	0.35	0.3
IL-17	0.97 (p  )	0.41	0.07
IL-6	0.94 (p  )	0.59	0.0001
TNF-α	0.96 (p  )	0.43	0.0002
IL-1β	0.97 (p  )	0.08	0.001
Vitamin D	−0.48 (p  )	−0.28	0.001

Dependent variable: NGAL; β: standardized coefficient of correlation.
NGAL: neutrophil gelatinase associated lipocalin; IL-17: interleukin-17; IL-6: interleukin-6; IL-1β: interleukin-1 beta; IFN-γ: interferon-gamma; TNF-α: tumor necrosis factor-alpha; hsCRP: high-sensitivity C-reactive protein; ESR: erythrocyte sedimentation rate.